Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency. - Wikidata - thesis-toulmin - TriplyDB

Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency.

Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency.

http://www.wikidata.org/entity/Q34762274

about

Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor iNKT Cells and Their Potential Lipid Ligands during Viral Infection Turned on by danger: activation of CD1d-restricted invariant natural killer T cells New ways to turn on NKT cells Invariant natural killer T cells and their ligands: focus on multiple sclerosis Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells Linking inflammation to natural killer T cell activation.Stimulation of natural killer T cells by glycolipids Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.Involvement of natural killer T cells in halothane-induced liver injury in mice Glycolipid antigen induces long-term natural killer T cell anergy in mice.CD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis.Invariant natural killer T cells as sensors and managers of inflammation.Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration.The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian α-linked glycosylceramides.Role of Innate T Cells in Anti-Bacterial Immunity.iNKT cell autoreactivity: what is 'self' and how is it recognized?Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells.Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals Natural killer T cells: know thyself.Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders Making memory at birth: understanding the differentiation of natural killer T cells The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion.Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice.alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant.Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation The role of invariant natural killer T cells in lupus and atherogenesis The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines.Does the developmental status of Valpha14i NKT cells play a role in disease?STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection CD1d presentation of glycolipids.beta-Glycosphingolipids as immune modulators.CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.

P2860

Q24672186-7E6C2F78-E8CF-4400-807C-2E4EC5F1946C Q26800120-D7895E05-6C6B-406D-92B1-AD904D34B116 Q26825059-930C440F-C67D-4323-910D-260C8578F005 Q27693911-EC1EB88E-545B-4972-93C3-078661817701 Q28083069-8A54633B-B474-405E-8D98-DB0765FCEE8E Q28505051-F5FA8DDB-290A-45D8-9CB0-378152D6C9D0 Q33512902-7EA42418-CA8F-4F28-8E0B-785EAA7D0B70 Q33599059-02C50ADD-ACEB-43EB-8D0C-ED1370B59B51 Q33599438-F43E709F-6CE4-49B9-A813-0D1F2AB2E605 Q33724575-98C62402-2D91-4C2E-AA40-F904B8D01CA6 Q33924798-B8FBA51B-9F06-43C9-94CE-62897EF2A942 Q33930869-46927C27-73F0-46DB-A3B0-2C540815AD41 Q33939552-A0797FDD-0D30-498C-AD75-18AE246AA8DF Q34302295-7B890E5D-A8D9-4D2B-91ED-EFF33D64234C Q34431108-0BF94309-5389-45CD-A198-019195DDC0A8 Q34453044-7BE0FB71-AD63-47C4-A693-4019F5584312 Q34482936-5DCD8AA5-5780-42F2-8C7B-CF77B9AAD1FC Q34760309-FE413B6C-A18D-458F-AD14-8DA49AF1427C Q35104944-D53177A5-A53A-4787-A964-E4BF98B0DD42 Q35131643-0A28F1A7-DF07-4166-BC9D-40B7F77F1B1F Q35195374-6F37F2CB-3956-44A2-8B50-8A46D282DE63 Q35622939-A4CB4EBA-CF2A-42C1-898C-3F8D7EF1679E Q35749476-F1382253-1B8D-468B-A3C6-F723E79DDDDA Q35749602-6936DC00-1F2B-42AE-AE27-07A322417BC2 Q35749606-67337EFA-9201-4208-B87E-175626C2BF7B Q35761273-8F98627D-49F9-4037-B8C4-D64E4396351F Q35870831-89C71CF3-9679-483B-8E96-0959D301E98F Q35978664-69045E72-75D5-4958-90E0-D2A172559CF9 Q35982680-B191301C-C3C1-4377-84C7-2430E610A97B Q35998799-5ACD2FDB-ED34-4CC9-B6BA-3437B5214C12 Q36097099-18EA3A9E-7524-40D0-9107-345AB785C3E9 Q36300047-2E3EFC28-0016-4AA7-9F00-09D716D9DB6B Q36487076-BDBFF0D8-1688-4F25-BBB6-3FFFDF0D0154 Q36536904-8AF88349-58A3-48AC-9E68-29A03F8C3A77 Q36586297-3EA150D7-EE6A-4F51-BEEF-ED23523769E5 Q36799673-082F5002-6512-45A0-9B5A-0C866212CCCF Q37127325-1B3C7EF5-5A16-40FD-97BB-6977309DDACE Q37187358-525FF323-B7E0-4EED-B9A2-76DF2635AC6C Q37196707-18052422-6732-4A96-A229-4DE0C1D32B5B Q37207409-B10A15EA-D380-48E4-B14A-F33AE4DDC784

P2860

Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency.

http://www.wikidata.org/entity/Q34762274

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

name

Defective presentation of the ...... lceramide synthase deficiency.

@ast

Defective presentation of the ...... lceramide synthase deficiency.

@en

Defective presentation of the ...... lceramide synthase deficiency.

@nl

type

label

Defective presentation of the ...... lceramide synthase deficiency.

@ast

Defective presentation of the ...... lceramide synthase deficiency.

@en

Defective presentation of the ...... lceramide synthase deficiency.

@nl

prefLabel

Defective presentation of the ...... lceramide synthase deficiency.

@ast

Defective presentation of the ...... lceramide synthase deficiency.

@en

Defective presentation of the ...... lceramide synthase deficiency.

@nl

P1433

Q34762274-A55BD096-C621-428E-81F1-4A0D1F4A65F4

P1476

Q34762274-03D8D9C6-CE77-4549-A397-6B08E6DF4EA9

P2093

Q34762274-00E64CB4-2CCD-4F95-A594-8CB38AE539B0

Q34762274-172ECB73-4568-4AA1-BE01-455B70C441C3

Q34762274-39F824EB-D8A9-4BA1-B547-157F0818341D

Q34762274-7349494E-DB63-43BD-99DE-08E1A9E54E09

Q34762274-C7AA10B8-9AF5-42D6-89BA-E9BD13103712

Q34762274-FE580291-1E6C-41E3-B48A-D277C3C4A452

P2860

Q34762274-08FE3A94-3F54-464E-A193-436F50E70A2B

Q34762274-1536EF7E-126B-40F9-B4F8-A9C8A297CDC3

Q34762274-1A5A11E2-9FC1-42B0-B193-EC775AAD0FB9

Q34762274-1DE1620F-AF9A-440E-8A57-7D78441E37E9

Q34762274-1F39A72F-2049-44F0-97AF-8EED2ACE77F0

Q34762274-2203A03B-31BD-48D2-824A-485B6321E0FD

Q34762274-2A2A715F-75B3-49E2-AB6A-ECBA2E3FF917

Q34762274-349611E9-BFB6-4545-BCAB-66F7D3A2B588

Q34762274-3D3FA759-DC0E-4F5A-B277-D04EFEB595E1

Q34762274-43777150-1447-4399-BEFA-170670A3EB5B

P304

Q34762274-DD629B38-671D-42AF-A748-4EAC48AE9800

P31

Q34762274-5B741BB6-05DB-4578-9350-D9C6B55B28A4

P356

Q34762274-F436327C-0480-4247-B318-AED2A001142A

P407

Q34762274-D10DF1DE-9DB1-41A7-A0DF-77B7F8A47E0C

P433

Q34762274-1AE5069E-5703-4908-8579-742BEFC7BEF1

P478

Q34762274-7C942428-926B-4FC8-BFE0-33F90331780C

P50

Q34762274-13000172-27B7-4FEB-A295-28E6B334E88E

Q34762274-4F5FF8AC-9A88-4883-9E08-12F7013B2C2D

Q34762274-800E28AC-F577-4DC1-9FB0-09797AA5ABB9

Q34762274-8FDD955E-D057-470F-9F2D-A330FB25B4AC

P577

Q34762274-C9396FF2-809E-4CCA-81C0-74313535F3D2

P5875

Q34762274-AF478E01-C8E2-4452-A1D0-31F88B0F5F4A

P698

Q34762274-16604A68-1893-4BE3-ABB2-485CAB540574

P921

Q34762274-656579EE-2D25-4EC6-AEA8-79364C6249B7

P932

Q34762274-3F166FD7-33C5-437C-83AE-C4CA8FD39FF3

P356

PNAS.0430327100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Defective presentation of the ...... lceramide synthase deficiency.

@en

P2093

A Dharshan De Silva

http://www.w3.org/2001/XMLSchema#string

Jang-June Park

http://www.w3.org/2001/XMLSchema#string

Kyoko Hayakawa

http://www.w3.org/2001/XMLSchema#string

Shinichi Ichikawa

http://www.w3.org/2001/XMLSchema#string

Venkataraman Sriram

http://www.w3.org/2001/XMLSchema#string

Yoshio Hirabyashi

http://www.w3.org/2001/XMLSchema#string

P2860

Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules

CD1d and natural T cells: how their properties jump-start the immune system

Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

The immunological synapse: a molecular machine controlling T cell activation

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

Phenotypic analysis of antigen-specific T lymphocytes

Topology of sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl sphingolipids is required for higher glycosphingolipid biosynthesis

CD1 recognition by mouse NK1+ T lymphocytes

CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4

P304

1849-1854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0430327100

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Aleksandar K Stanic

Sebastian Joyce

Randy R Brutkiewicz

P577

2003-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10908806

http://www.w3.org/2001/XMLSchema#string

P698

12576547

http://www.w3.org/2001/XMLSchema#string

P921

P932

149922

http://www.w3.org/2001/XMLSchema#string